Literature DB >> 30487138

Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.

Melissa A Buckley1,2, Nicholas T Woods1,3, Jonathan P Tyrer4, Gustavo Mendoza-Fandiño1, Kate Lawrenson5, Dennis J Hazelett6,7,8, Hamed S Najafabadi9,10, Anxhela Gjyshi1,2, Renato S Carvalho1, Paulo C Lyra1, Simon G Coetzee8, Howard C Shen6, Ally W Yang9, Madalene A Earp11, Sean J Yoder12, Harvey Risch13, Georgia Chenevix-Trench14, Susan J Ramus15,16, Catherine M Phelan1, Gerhard A Coetzee6,17, Houtan Noushmehr18, Timothy R Hughes9,19,20, Thomas A Sellers1, Ellen L Goode11, Paul D Pharoah4, Simon A Gayther5,21, Alvaro N A Monteiro.   

Abstract

Genome-wide association studies have identified 40 ovarian cancer risk loci. However, the mechanisms underlying these associations remain elusive. In this study, we conducted a two-pronged approach to identify candidate causal SNPs and assess underlying biological mechanisms at chromosome 9p22.2, the first and most statistically significant associated locus for ovarian cancer susceptibility. Three transcriptional regulatory elements with allele-specific effects and a scaffold/matrix attachment region were characterized and, through physical DNA interactions, BNC2 was established as the most likely target gene. We determined the consensus binding sequence for BNC2 in vitro, verified its enrichment in BNC2 ChIP-seq regions, and validated a set of its downstream target genes. Fine-mapping by dense regional genotyping in over 15,000 ovarian cancer cases and 30,000 controls identified SNPs in the scaffold/matrix attachment region as among the most likely causal variants. This study reveals a comprehensive regulatory landscape at 9p22.2 and proposes a likely mechanism of susceptibility to ovarian cancer. SIGNIFICANCE: Mapping the 9p22.2 ovarian cancer risk locus identifies BNC2 as an ovarian cancer risk gene.See related commentary by Choi and Brown, p. 439. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30487138      PMCID: PMC6359979          DOI: 10.1158/0008-5472.CAN-17-3864

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificities.

Authors:  Michael F Berger; Anthony A Philippakis; Aaron M Qureshi; Fangxue S He; Preston W Estep; Martha L Bulyk
Journal:  Nat Biotechnol       Date:  2006-09-24       Impact factor: 54.908

2.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

3.  Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.

Authors:  Kexin Chen; Hongxia Ma; Lian Li; Rongyu Zang; Cheng Wang; Fengju Song; Tingyan Shi; Dianke Yu; Ming Yang; Wenqiong Xue; Juncheng Dai; Shuang Li; Hong Zheng; Chen Wu; Ying Zhang; Xiaohua Wu; Dake Li; Fengxia Xue; Haixin Li; Zhi Jiang; Jibin Liu; Yuexin Liu; Pei Li; Wen Tan; Jing Han; Jiang Jie; Quan Hao; Zhibin Hu; Dongxin Lin; Ding Ma; Weihua Jia; Hongbing Shen; Qingyi Wei
Journal:  Nat Commun       Date:  2014-08-19       Impact factor: 14.919

4.  Principles for the post-GWAS functional characterization of cancer risk loci.

Authors:  Matthew L Freedman; Alvaro N A Monteiro; Simon A Gayther; Gerhard A Coetzee; Angela Risch; Christoph Plass; Graham Casey; Mariella De Biasi; Chris Carlson; David Duggan; Michael James; Pengyuan Liu; Jay W Tichelaar; Haris G Vikis; Ming You; Ian G Mills
Journal:  Nat Genet       Date:  2011-06       Impact factor: 38.330

Review 5.  Association studies for finding cancer-susceptibility genetic variants.

Authors:  Paul D P Pharoah; Alison M Dunning; Bruce A J Ponder; Douglas F Easton
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

6.  A map of human genome variation from population-scale sequencing.

Authors:  Gonçalo R Abecasis; David Altshuler; Adam Auton; Lisa D Brooks; Richard M Durbin; Richard A Gibbs; Matt E Hurles; Gil A McVean
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

7.  Large-scale gene function analysis with the PANTHER classification system.

Authors:  Huaiyu Mi; Anushya Muruganujan; John T Casagrande; Paul D Thomas
Journal:  Nat Protoc       Date:  2013-07-18       Impact factor: 13.491

8.  Resurrecting surviving Neandertal lineages from modern human genomes.

Authors:  Benjamin Vernot; Joshua M Akey
Journal:  Science       Date:  2014-01-29       Impact factor: 47.728

9.  Human skin color is influenced by an intergenic DNA polymorphism regulating transcription of the nearby BNC2 pigmentation gene.

Authors:  Mijke Visser; Robert-Jan Palstra; Manfred Kayser
Journal:  Hum Mol Genet       Date:  2014-06-10       Impact factor: 6.150

10.  Basonuclin 2: an extremely conserved homolog of the zinc finger protein basonuclin.

Authors:  Amandine Vanhoutteghem; Philippe Djian
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

View more
  8 in total

1.  Expanding the knowledge on development of CAKUT: molecular genetics and beyond.

Authors:  Gabriel C Dworschak; Heiko Reutter; Alina C Hilger
Journal:  Ann Transl Med       Date:  2019-10

2.  Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locus.

Authors:  Gustavo Mendoza-Fandiño; Paulo Cilas M Lyra; Thales C Nepomuceno; Carly M Harro; Nicholas T Woods; Xueli Li; Leticia B Rangel; Marcelo A Carvalho; Fergus J Couch; Alvaro N A Monteiro
Journal:  Eur J Hum Genet       Date:  2021-11-22       Impact factor: 4.246

3.  Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.

Authors:  Koji Nakamura; Brett M Reid; Ann Chen; Zhihua Chen; Ellen L Goode; Jennifer B Permuth; Jamie K Teer; Jonathan Tyrer; Xiaoqing Yu; Peter A Kanetsky; Paul D Pharoah; Simon A Gayther; Thomas A Sellers; Kate Lawrenson; Florian A Karreth
Journal:  Am J Hum Genet       Date:  2021-12-28       Impact factor: 11.043

4.  Functional genomic analysis delineates regulatory mechanisms of GWAS-identified bipolar disorder risk variants.

Authors:  Rui Chen; Zhihui Yang; Jiewei Liu; Xin Cai; Yongxia Huo; Zhijun Zhang; Ming Li; Hong Chang; Xiong-Jian Luo
Journal:  Genome Med       Date:  2022-05-20       Impact factor: 15.266

5.  Meta-Analyses of Splicing and Expression Quantitative Trait Loci Identified Susceptibility Genes of Glioma.

Authors:  C Pawan K Patro; Darryl Nousome; Rose K Lai
Journal:  Front Genet       Date:  2021-04-15       Impact factor: 4.772

6.  The landscape of GWAS validation; systematic review identifying 309 validated non-coding variants across 130 human diseases.

Authors:  Ammar J Alsheikh; Sabrina Wollenhaupt; Emily A King; Jonas Reeb; Sujana Ghosh; Lindsay R Stolzenburg; Saleh Tamim; Jozef Lazar; J Wade Davis; Howard J Jacob
Journal:  BMC Med Genomics       Date:  2022-04-01       Impact factor: 3.063

7.  Functional genomics elucidates regulatory mechanisms of Parkinson's disease-associated variants.

Authors:  Rui Chen; Jiewei Liu; Shiwu Li; Xiaoyan Li; Yongxia Huo; Yong-Gang Yao; Xiao Xiao; Ming Li; Xiong-Jian Luo
Journal:  BMC Med       Date:  2022-02-16       Impact factor: 8.775

8.  Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis.

Authors:  Marie Bobowski-Gerard; Clémence Boulet; Francesco P Zummo; Julie Dubois-Chevalier; Céline Gheeraert; Mohamed Bou Saleh; Jean-Marc Strub; Amaury Farce; Maheul Ploton; Loïc Guille; Jimmy Vandel; Antonino Bongiovanni; Ninon Very; Eloïse Woitrain; Audrey Deprince; Fanny Lalloyer; Eric Bauge; Lise Ferri; Line-Carolle Ntandja-Wandji; Alexia K Cotte; Corinne Grangette; Emmanuelle Vallez; Sarah Cianférani; Violeta Raverdy; Robert Caiazzo; Viviane Gnemmi; Emmanuelle Leteurtre; Benoit Pourcet; Réjane Paumelle; Kim Ravnskjaer; Guillaume Lassailly; Joel T Haas; Philippe Mathurin; François Pattou; Laurent Dubuquoy; Bart Staels; Philippe Lefebvre; Jérôme Eeckhoute
Journal:  Nat Commun       Date:  2022-09-10       Impact factor: 17.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.